Inventor
Arne Agerlin Olsen
Inventor
Virum, DK
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C11Dprimary
C11DDetergent compositions17%
C12NMicroorganisms or enzymes16%
A61KPreparations for medical, dental or toiletry purposes14%
C12YEnzymes9%
A61QSpecific use of cosmetics or similar toiletry preparations7%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms7%
D21CProduction of cellulose by removing non-cellulose substances from cellulose-containing materials7%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
H01SDevices using the process of light amplification by stimulated emission of radiation [laser] to amplify or generate light4%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations2%
PatentTitleYear
8,889,128'Use of the endoglycosidase endos for treating immunoglobulin G mediated diseases'20146,686,164'Low allergenic protein variants'20046,638,526'Polypeptides conjugated to copolymers of ethylene oxide and propylene oxide to reduce allergenicity'20036,623,950'Modified enzymes having polymer conjugates'20036,461,849'Modified polypeptide'20026,416,756'Modified protease having 5 to 13 covalently coupled polymeric molecules for skin care'20026,303,752'Polypeptides conjugated with polymers'20016,280,984'DNA constructs and methods of producing cellulytic enzymes'20016,245,901'Modified polypeptide'20016,242,210'Treatment of bacterial infections'20016,234,053'Label stacker for a rotary machine/apparatus'20016,221,845'Use of kinin antagonists for preparing a pharmaceutical composition for treating bacterial infections'20016,201,110'Polypeptide with reduced respiratory allergenicity'20016,114,509'Polypeptide with reduced allergenicity'20006,106,828'Conjugation of polypeptides'20006,030,805'Fibronectin binding protein as well as its preparation'20006,017,749'Alkalophilic Bacillus sp. AC13 and protease, xylanase, cellulase obtainable therefrom'20005,981,253'Alkalophilic Bacillus sp. AC13 and protease, xylanase, cellulase obtainable therefrom'19995,981,718'Polypeptide with reduced allergenicity'19995,945,327'DNA constructs and methods of producing cellulytic enzymes'19995,922,586'DNA constructs and methods of producing cellulytic enzymes'19995,866,526'Enzyme preparation comprising a modified enzyme'19995,856,451'Method for reducing respiratory allergenicity'19995,770,424'DNA constructs and methods of producing xylanolytic enzymes'19985,741,693'Alkalophilic bacillus SP. AC13 and protease, xylanase, cellulase obtainable therefrom'19985,696,068'Alkalophilic Bacillus sp. AC13 and protease, xylanase, cellulase obtainable therefrom'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2001Patents assigned to NOVO NORDISK AS (14)· patent assignee history
1997–2003Based in Virum, DK· patent location history
2001–2004Patents assigned to NOVOZYMES AS (7)· patent assignee history
2001Patents assigned to ACTINOVA LTD (2)· patent assignee history
2001Based in Bjarred, SE· patent location history
2001Based in Drag.o slashed.r, DK· patent location history
2004Based in Kaplevej, DK· patent location history
2014Patents assigned to BJÖRCK LARS (1)· patent assignee history
2014Patents assigned to COLLIN MATTIAS (1)· patent assignee history
2014Based in Onsala, SE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVO NORDISK AS | 14 | 1997–2001 |
| NOVOZYMES AS | 7 | 2001–2004 |
| ACTINOVA LTD | 2 | 2001 |
| BJÖRCK LARS | 1 | 2014 |
| COLLIN MATTIAS | 1 | 2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Virum, DK | 20 | 1997–2003 |
| Onsala, SE | 1 | 2014 |
| Kaplevej, DK | 1 | 2004 |
| Bjarred, SE | 1 | 2001 |
| Drag.o slashed.r, DK | 1 | 2001 |